Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P van Tintelen

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 2, 2008
The many faces of aggressive aortic pathology: Loeys-Dietz syndromeJ J J Aalberts, M P van den Berg, J E H Bergman, et al.
Neuropediatrics|June 10, 2005
Neonatal lactic acidosis, complex I/IV deficiency, and fetal cerebral disruptionH L M van Straaten, J P van Tintelen, J M F Trijbels, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|December 2, 2009
Founder mutations in the Netherlands: SCN5a 1795insD, the first described arrhythmia overlap syndrome and one of the largest and best characterised families worldwideP G Postema, M Van den Berg, J P Van Tintelen, et al.
Clinical Genetics|August 20, 2010
Desmin-related myopathyK Y van Spaendonck-Zwarts, L van Hessem, J D H Jongbloed, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 5, 2010
Recurrent and founder mutations in the Netherlands: Extensive clinical variability in Marfan syndrome patients with a single novel recurrent fibrillin-1 missense mutationJ J J Aalberts, A G Schuurman, G Pals, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 29, 2019
UNRAVEL: big data analytics research data platform to improve care of patients with cardiomyopathies using routine electronic health records and standardised biobankingA Sammani, M Jansen, M Linschoten, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 28, 2010
Founder mutations in hypertrophic cardiomyopathy patients in the NetherlandsI Christiaans, E A Nannenberg, D Dooijes, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
A large family characterised by nocturnal sudden deathM P van den Berg, J W Viersma, G C M Beaufort-Krol, et al.
Clinical Genetics|February 22, 2011
Critical appraisal of the revised Ghent criteria for diagnosis of Marfan syndromeT Radonic, P de Witte, M Groenink, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 3, 2011
Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathyA van den Wijngaard, P Volders, J P Van Tintelen, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 2, 2008
The many faces of aggressive aortic pathology: Loeys-Dietz syndromeJ J J Aalberts, M P van den Berg, J E H Bergman, et al.
Neuropediatrics|June 10, 2005
Neonatal lactic acidosis, complex I/IV deficiency, and fetal cerebral disruptionH L M van Straaten, J P van Tintelen, J M F Trijbels, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|December 2, 2009
Founder mutations in the Netherlands: SCN5a 1795insD, the first described arrhythmia overlap syndrome and one of the largest and best characterised families worldwideP G Postema, M Van den Berg, J P Van Tintelen, et al.
Clinical Genetics|August 20, 2010
Desmin-related myopathyK Y van Spaendonck-Zwarts, L van Hessem, J D H Jongbloed, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 5, 2010
Recurrent and founder mutations in the Netherlands: Extensive clinical variability in Marfan syndrome patients with a single novel recurrent fibrillin-1 missense mutationJ J J Aalberts, A G Schuurman, G Pals, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 29, 2019
UNRAVEL: big data analytics research data platform to improve care of patients with cardiomyopathies using routine electronic health records and standardised biobankingA Sammani, M Jansen, M Linschoten, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 28, 2010
Founder mutations in hypertrophic cardiomyopathy patients in the NetherlandsI Christiaans, E A Nannenberg, D Dooijes, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
A large family characterised by nocturnal sudden deathM P van den Berg, J W Viersma, G C M Beaufort-Krol, et al.
Clinical Genetics|February 22, 2011
Critical appraisal of the revised Ghent criteria for diagnosis of Marfan syndromeT Radonic, P de Witte, M Groenink, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 3, 2011
Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathyA van den Wijngaard, P Volders, J P Van Tintelen, et al.
Pageof 5